Clinical Trials Directory

Trials / Conditions / Metastatic Squamous Cell Carcinoma

Metastatic Squamous Cell Carcinoma

10 registered clinical trials studyying Metastatic Squamous Cell Carcinoma — 4 currently recruiting.

StatusTrialSponsorPhase
Not Yet Recruiting5-Fluorouracil Response and Optimization STudy (The FROST Trial)
NCT07419464
Washington University School of MedicinePhase 2
RecruitingDose Finding Study of Zanzalintinib With Pembrolizumab and Cetuximab in Head and Neck SCC
NCT06912087
University of ChicagoPhase 1
WithdrawnASTX727 and Nivolumab in Squamous Cell Carcinoma of the Head and Neck
NCT06357858
Case Comprehensive Cancer CenterPhase 1
Active Not RecruitingTBio-4101 and Pembro wi/ or w/o Chemo in Recurrent/Metastatic HNSCC
NCT06236425
H. Lee Moffitt Cancer Center and Research InstitutePhase 1
UnknownA Clinical Trial of TQB2618 Injection Combined With Penpulimab Injection and Chemotherapy Versus Penpulimab In
NCT05783921
Chia Tai Tianqing Pharmaceutical Group Co., Ltd.Phase 1 / Phase 2
RecruitingCombination of Spartalizumab, mDCF and Radiotherapy in Patients With Metastatic Squamous Cell Anal Carcinoma
NCT04894370
Centre Hospitalier Universitaire de BesanconPhase 2
RecruitingFirst Line Weekly Chemo/Immunotherapy for Metastatic Head/Neck Squamous Cell Carcinoma Patients
NCT04858269
Wake Forest University Health SciencesPhase 2
CompletedIRX-2 Regimen and Durvalumab, for Incurable H&N Squamous Cell Carcinoma
NCT03381183
H. Lee Moffitt Cancer Center and Research InstitutePhase 1
CompletedStudy of ADXS-503 With or Without Pembro in Subjects With Metastatic Non-Small Cell Lung Cancer
NCT03847519
Advaxis, Inc.Phase 1 / Phase 2
Active Not RecruitingImmunotherapy and SBRT for Metastatic Head and Neck Carcinomas
NCT03283605
Centre hospitalier de l'Université de Montréal (CHUM)Phase 1 / Phase 2